Tumor imaging with the estrogen receptor radioligand Z-[I-123]MIVE in patients with metastatic breast cancer.

被引：0
|
作者：
Rijks, LJM
Bakker, PJM
Veenhof, CHN
Boer, GJ
deBruin, K
Janssen, AGM
vanRoyen, EA
机构：
[1] TECH UNIV EINDHOVEN,CYGNE BV,NL-5600 MB EINDHOVEN,NETHERLANDS
[2] UNIV AMSTERDAM,ACAD MED CTR,DEPT NUCL MED,NL-1105 AZ AMSTERDAM,NETHERLANDS
[3] UNIV AMSTERDAM,ACAD MED CTR,DEPT MED ONCOL,NL-1105 AZ AMSTERDAM,NETHERLANDS
来源：
JOURNAL OF NUCLEAR MEDICINE | 1996年 / 37卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1835 / 1835
页数：2
相关论文
共 50 条
  • [1] Z-[I-123]MIVE estrogen receptor imaging in breast cancer.
    Rijks, LJM
    vanTienhoven, G
    Bakker, PJM
    Noorduyn, LA
    Rietbroek, RC
    Taat, CW
    deBruin, K
    Janssen, AGM
    Veenhof, CHN
    vanRoyen, EA
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 68 - 68
  • [2] First results with the estrogen receptor radioligand Z-[I-123]MIVE in metastatic breast cancer patients
    Rijks, LJM
    Bakker, PJM
    Veenhof, CHN
    Janssen, AGM
    vanRoyen, EA
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 675 - 675
  • [3] Biodistribution and dosimetry of Z-[I-123]MIVE: An estrogen receptor radioligand for breast cancer imaging.
    Rijks, LJM
    BusemannSokole, E
    Stabin, M
    deBruin, K
    Janssen, AGM
    vanRoyen, EA
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 965 - 965
  • [4] Imaging of primary breast tumors with the estrogen receptor specific radioligand Z-[I-123]MIVE.
    Rijks, LJM
    vanTienhoven, G
    deBruin, K
    Boer, GJ
    Janssen, AGM
    vanRoyen, EA
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (10) : 1836 - 1836
  • [5] Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE
    Rijks, LJM
    Bakker, PJM
    vanTienhoven, G
    Noorduyn, LA
    Boer, GJ
    Rietbroek, RC
    Taat, CW
    Janssen, AGM
    Veenhof, CHN
    vanRoyen, EA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) : 2536 - 2545
  • [6] Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging
    Rijks, LJM
    Sokole, EB
    Stabin, MG
    de Bruin, K
    Janssen, AGM
    van Royen, EA
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (01): : 40 - 47
  • [7] Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: An oestrogen receptor radioligand for breast cancer imaging
    Rijks L.J.M.
    Sokole E.B.
    Stabin M.G.
    De Bruin K.
    Janssen A.G.M.
    Van Royen E.A.
    [J]. European Journal of Nuclear Medicine, 1998, 25 (1) : 40 - 47
  • [8] Androgen receptor and estrogen receptor imaging in patients with metastatic breast cancer.
    Venema, Clasina Marieke
    Mammatas, Lemonitsa H.
    van Kruchten, Michel
    Apollonio, Giulia
    Schroder, Carolina Pia
    Glaudemans, Andor W. J. M.
    Hoekstra, Otto S.
    Verheul, Henk M. W.
    van der Vegt, Bert
    De Vries, Erik F. J.
    De Vries, Elisabeth
    Menke, Catharina Wilhelmina
    Hospers, Geke
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Scintigraphic assessment of estrogen receptor status in primary breast cancer patients with I-123 labelled cis 11?-methoxy-17?-iodovinyl estradiol (Z-MIVE)
    Bennink, RJ
    Rijks, LJ
    Van Tienhoven, G
    Noorduyn, LA
    Janssen, AG
    Sloof, GW
    [J]. RADIOLOGY, 2000, 217 : 578 - 578
  • [10] The Z-isomer of 11 beta-methoxy-17 alpha-[I-123]iodovinylestradiol is a promising radioligand for estrogen receptor imaging in human breast cancer
    Rijks, LJM
    Boer, GJ
    Endert, E
    deBruin, K
    Janssen, AGM
    vanRoyen, EA
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (01) : 65 - 75
12345